Common sense treatment for common lipid disorders

Mo Med. 2011 Mar-Apr;108(2):107-12.

Abstract

Dyslipidemia is a common, major modifiable risk factor for cardiovascular disease. Screening for lipid disorders is simple, and available treatments decrease disease risk. However, secondary causes of dyslipidemia are probably underappreciated, and severe lipid elevations should be referred to a lipid specialist. Patients usually respond to lifestyle modifications and drug therapy guided by a stepwise approach supported by the results of clinical trials, but several misconceptions may interfere with treatment strategies.

Publication types

  • Review

MeSH terms

  • Cholesterol, LDL / blood
  • Comorbidity
  • Diabetic Angiopathies / blood
  • Diabetic Angiopathies / drug therapy
  • Dyslipidemias / blood
  • Dyslipidemias / drug therapy*
  • Dyslipidemias / epidemiology
  • Dyslipidemias / etiology
  • Dyslipidemias / physiopathology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Hypertriglyceridemia / drug therapy
  • Hypertriglyceridemia / etiology
  • Life Style

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors